These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1595639)

  • 1. Incorporating randomized clinical trials into clinical practice: maintenance treatment for Crohn's disease.
    Lashner BA
    Am J Gastroenterol; 1992 May; 87(5):549-50. PubMed ID: 1595639
    [No Abstract]   [Full Text] [Related]  

  • 2. Current treatment for prevention of relapse and recurrence in Crohn's disease.
    Prantera C; Scribano ML
    Ital J Gastroenterol Hepatol; 1999; 31(6):515-8. PubMed ID: 10575572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-inflammatory properties of interleukin-10 in human Crohn's disease: much to learn, much to explore].
    Stallmach A; Schmidt C; Marth T
    Z Gastroenterol; 2002 Jun; 40(6):475-7. PubMed ID: 12055668
    [No Abstract]   [Full Text] [Related]  

  • 4. A meta-analysis of antimycobacterial therapy for Crohn's disease.
    Borgaonkar MR; MacIntosh DG; Fardy JM
    Am J Gastroenterol; 2000 Mar; 95(3):725-9. PubMed ID: 10710065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.
    Sandborn WJ; Feagan BG; Lichtenstein GR
    Aliment Pharmacol Ther; 2007 Oct; 26(7):987-1003. PubMed ID: 17877506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In favour of prophylactic treatment for post-operative recurrence in Crohn's disease.
    Caprilli R; Taddei G; Viscido A
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):219-25. PubMed ID: 9675663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical and internal medicine therapy study of the postoperative prevention of recurrence in Crohn's disease - completion of a partly randomized study].
    Ewe K; Herfarth C; Malchow H
    Verh Dtsch Ges Inn Med; 1980; 86():1327-37. PubMed ID: 7013325
    [No Abstract]   [Full Text] [Related]  

  • 8. Nutrition and Crohn's disease: an update of print and Web-based guidance.
    Moorthy D; Cappellano KL; Rosenberg IH
    Nutr Rev; 2008 Jul; 66(7):387-97. PubMed ID: 18667014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative Crohn's disease: prevention and treatment.
    El-Hachem S; Regueiro M
    Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):249-56. PubMed ID: 19485807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indications and results of infliximab in Crohn's disease].
    Karoui S; Boubaker J; Filali A
    Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.
    Steinhart AH; Hemphill D; Greenberg GR
    Am J Gastroenterol; 1994 Dec; 89(12):2116-24. PubMed ID: 7977225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin in Crohn's disease. Therapeutic and pathogenetic implications.
    Brynskov J
    Dan Med Bull; 1994 Jun; 41(3):332-44. PubMed ID: 7924462
    [No Abstract]   [Full Text] [Related]  

  • 13. Natalizumab. Elan/Biogen.
    Elices MJ
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1354-62. PubMed ID: 14758775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of post-surgical recurrence of Crohn's disease. A perspective].
    Paviotti A; Terrosu G; Avellini C; Girometti R; Sorrentino D
    Recenti Prog Med; 2009 May; 100(5):233-8. PubMed ID: 19772213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical practice guideline on diagnosis and treatment of Crohn's disease].
    Hoffmann JC; Preiss JC; Autschbach F; Buhr HJ; Häuser W; Herrlinger K; Höhne W; Koletzko S; Krieglstein CF; Kruis W; Matthes H; Moser G; Reinshagen M; Rogler G; Schreiber S; Schreyer AG; Sido B; Siegmund B; Stallmach A; Bokemeyer B; Stange EF; Zeitz M
    Z Gastroenterol; 2008 Sep; 46(9):1094-146. PubMed ID: 18810679
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral mesalazine for the treatment of Crohn's disease: clinical efficacy with respect to pharmacokinetic properties.
    Tromm A; Griga T; May B
    Hepatogastroenterology; 1999; 46(30):3124-35. PubMed ID: 10626173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's disease.
    Rahimi R; Nikfar S; Rezaie A; Abdollahi M
    Clin Ther; 2006 Dec; 28(12):1983-8. PubMed ID: 17296455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natalizumab: a new hope for Crohn's disease?
    Napier J; Wong RK
    Am J Gastroenterol; 2003 May; 98(5):1197-9. PubMed ID: 12830820
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral budesonide for maintenance of remission of Crohn's disease: a pooled safety analysis.
    Lichtenstein GR; Bengtsson B; Hapten-White L; Rutgeerts P
    Aliment Pharmacol Ther; 2009 Mar; 29(6):643-53. PubMed ID: 19035972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease: increased relapse rate the following year.
    Vilien M; Dahlerup JF; Munck LK; Nørregaard P; Grønbaek K; Fallingborg J
    Aliment Pharmacol Ther; 2004 Jun; 19(11):1147-52. PubMed ID: 15153167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.